Butterfly Corp (BFLY) - Rasio tanggungan utang jangka dawa marang modal

Butterfly Network, Inc. - logo grafis emiten BFLY

Butterfly Network, Inc. (BFLY) is protected by exclusive patents for ultrasound-on-a-chip technology and stringent government regulations. The business relies on a cloud network of portable sensors with high physician loyalty and AI certification. The environmental strategy is implemented through energy-efficient systems and secure supply chains, while the standalone debt metric stands at 0.10. The stock price trend on the GURU.Markets platform clearly demonstrates the current price action of this diagnostic equipment developer.

Butterfly Network (BFLY): Utang jangka dawa marang modal saka 04.07.2022 nganti 29.10.2026
Sampel barang Butterfly iQ

The development of Butterfly Network, Inc. (BFLY) in the field of portable ultrasound-on-a-chip and AI diagnostics is reflected in the dynamics of its long-term debt-to-equity ratio. This indicator is calculated as the ratio of liabilities with a maturity of over one year to equity, allowing investors to assess the sustainability of the financial leverage and the extent to which the company's innovative leadership depends on external debt financing.

Perusahaan pesaing

Rasio utang jangka dawa marang modal ABT (Abbott Labs)|Utang jangka dawa marang modal TMO|Rasio tanggungan utang jangka dawa marang modal GE HealthCare Inc.|Utang jangka dawa marang modal MTD (Mettler-Toledo International)|Utang jangka dawa marang modal waters.com WAT|Bio-Techne - Utang jangka dawa marang modal|Tanggungan utang jangka dawa marang ekuitas Bruker Corp (BRKR)|Azenta Life Sciences (AZTA) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal VREX|Utang jangka dawa marang ekuitas Semler Scientific, Inc.|Kewajiban jangka dawa marang modal mesalabs.com MLAB|Utang jangka dawa marang ekuitas Quantum-Si Incorporated (QSI)|Rasio tanggungan utang jangka dawa marang modal Nano-X Imaging|Quanterix Corp - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka dawa marang modal MASS (908 Devices Corporation)|CapsoVision Medical - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal maxcyte.com MXCT|RPID: Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Seer Inc|Rasio utang jangka dawa marang ekuitas HYPR|FONR: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Daxor Corporation (DXR)|Rasio utang jangka dawa marang ekuitas Spectral AI Inc. MDAI|Utang jangka dawa marang modal VIVS (Organovo Holdings, Inc.)|Aclarion Inc (ACON) - Kewajiban jangka dawa marang modal|Akoya - Utang jangka dawa marang modal|THMO (Cesca Therapeutics) - Rasio utang jangka dawa marang modal|TLIS: Utang jangka dawa marang modal|TTOO - Rasio tanggungan utang jangka dawa marang modal